Your browser doesn't support javascript.
loading
Circulating BMP9 Protects the Pulmonary Endothelium during Inflammation-induced Lung Injury in Mice.
Li, Wei; Long, Lu; Yang, Xudong; Tong, Zhen; Southwood, Mark; King, Ross; Caruso, Paola; Upton, Paul D; Yang, Peiran; Bocobo, Geoffrey A; Nikolic, Ivana; Higuera, Angelica; Salmon, Richard M; Jiang, He; Lodge, Katharine M; Hoenderdos, Kim; Baron, Rebecca M; Yu, Paul B; Condliffe, Alison M; Summers, Charlotte; Nourshargh, Sussan; Chilvers, Edwin R; Morrell, Nicholas W.
Affiliation
  • Li W; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Long L; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Yang X; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Tong Z; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Southwood M; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
  • King R; William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Caruso P; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Upton PD; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Yang P; Cardiovascular Medicine Division and.
  • Bocobo GA; Cardiovascular Medicine Division and.
  • Nikolic I; Cardiovascular Medicine Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Higuera A; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital-Harvard Medical School, Harvard University, Boston, Massachusetts.
  • Salmon RM; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Jiang H; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Lodge KM; National Heart and Lung Institute, Imperial College London, London, United Kingdom; and.
  • Hoenderdos K; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Baron RM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital-Harvard Medical School, Harvard University, Boston, Massachusetts.
  • Yu PB; Cardiovascular Medicine Division and.
  • Condliffe AM; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
  • Summers C; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Nourshargh S; William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Chilvers ER; National Heart and Lung Institute, Imperial College London, London, United Kingdom; and.
  • Morrell NW; Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Am J Respir Crit Care Med ; 203(11): 1419-1430, 2021 06 01.
Article in En | MEDLINE | ID: mdl-33320799
Rationale: Pulmonary endothelial permeability contributes to the high-permeability pulmonary edema that characterizes acute respiratory distress syndrome. Circulating BMP9 (bone morphogenetic protein 9) is emerging as an important regulator of pulmonary vascular homeostasis. Objectives:To determine whether endogenous BMP9 plays a role in preserving pulmonary endothelial integrity and whether loss of endogenous BMP9 occurs during LPS challenge. Methods: A BMP9-neutralizing antibody was administrated to healthy adult mice, and lung vasculature was examined. Potential mechanisms were delineated by transcript analysis in human lung endothelial cells. The impact of BMP9 administration was evaluated in a murine acute lung injury model induced by inhaled LPS. Levels of BMP9 were measured in plasma from patients with sepsis and from endotoxemic mice. Measurements and Main Results: Subacute neutralization of endogenous BMP9 in mice (N = 12) resulted in increased lung vascular permeability (P = 0.022), interstitial edema (P = 0.0047), and neutrophil extravasation (P = 0.029) compared with IgG control treatment (N = 6). In pulmonary endothelial cells, BMP9 regulated transcriptome pathways implicated in vascular permeability and cell-membrane integrity. Augmentation of BMP9 signaling in mice (N = 8) prevented inhaled LPS-induced lung injury (P = 0.0027) and edema (P < 0.0001). In endotoxemic mice (N = 12), endogenous circulating BMP9 concentrations were markedly reduced, the causes of which include a transient reduction in hepatic BMP9 mRNA expression and increased elastase activity in plasma. In human patients with sepsis (N = 10), circulating concentratons of BMP9 were also markedly reduced (P < 0.0001). Conclusions: Endogenous circulating BMP9 is a pulmonary endothelial-protective factor, downregulated during inflammation. Exogenous BMP9 offers a potential therapy to prevent increased pulmonary endothelial permeability in lung injury.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Sepsis / Endotoxemia / Endothelium / Acute Lung Injury / Growth Differentiation Factor 2 Type of study: Etiology_studies / Observational_studies / Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Sepsis / Endotoxemia / Endothelium / Acute Lung Injury / Growth Differentiation Factor 2 Type of study: Etiology_studies / Observational_studies / Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Year: 2021 Type: Article